All Stories

  1. Rejection-Focused Precision Medicine in Kidney Transplantation: Biology, Biomarkers, and Artificial Intelligence
  2. Machine Learning-Assisted FTIR Spectroscopy Analysis of Kidney Preservation Fluids for Delayed Graft Function Risk Stratification
  3. FT-MIR Spectroscopy Coupled with Machine Learning for the Identification of Antimicrobial Spectral Markers in Marine Drug Discovery
  4. Comparison of Mid and Near-Infrared Spectroscopy to Predict Creatinine, Urea and Albumin in Serum Samples as Biomarkers of Renal Function
  5. Rapid FTIR Spectral Fingerprinting of Kidney Allograft Perfusion Fluids Distinguishes DCD from DBD Donors: A Pilot Machine Learning Study
  6. Multiplex Targeted Proteomic Analysis of Cytokine Ratios for ICU Mortality in Severe COVID-19
  7. Analyzing Heart Rate Variability for COVID-19 ICU Mortality Prediction Using Continuous Signal Processing Techniques
  8. Predictive Models of Patient Severity in Intensive Care Units Based on Serum Cytokine Profiles: Advancing Rapid Analysis
  9. Cytokine-Based Insights into Bloodstream Infections and Bacterial Gram Typing in ICU COVID-19 Patients
  10. Integration of FTIR Spectroscopy and Machine Learning for Kidney Allograft Rejection: A Complementary Diagnostic Tool
  11. Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope Helicobacter pylori Vaccines in a BALB/c Mouse Model
  12. Comparison of two metabolomics-platforms to discover biomarkers in critically ill patients from serum analysis
  13. Early Mortality Prediction in Intensive Care Unit Patients Based on Serum Metabolomic Fingerprint
  14. Analysis of six consecutive waves of ICU-admitted COVID-19 patients: key findings and insights from a Portuguese population
  15. Impact of neutrophil‐activating protein conservation on diagnostic tests and vaccine design
  16. Discovery of Delirium Biomarkers through Minimally Invasive Serum Molecular Fingerprinting
  17. A new methodology for a rapid and high‐throughput comparison of molecular profiles and biological activity of phytoextracts
  18. Bridging the gap between target-based and phenotypic-based drug discovery
  19. Enhancing Bioactive Compound Classification through the Synergy of Fourier-Transform Infrared Spectroscopy and Advanced Machine Learning Methods
  20. Simplifying Data Analysis in Biomedical Research: An Automated, User-Friendly Tool
  21. Enhancing Bioactive Compound Classification through the Synergy of Fourier-Transform Infrared Spectroscopy and Advanced Machine Learning Methods
  22. Predicting Cellular Rejection of Renal Allograft Based on the Serum Proteomic Fingerprint
  23. Exosomes and microvesicles in kidney transplantation: the long road from trash to gold
  24. The Characteristics and Laboratory Findings of SARS-CoV-2 Infected Patients during the First Three COVID-19 Waves in Portugal—A Retrospective Single-Center Study
  25. Blood molecular profile to predict genotoxicity from exposure to antineoplastic drugs
  26. A new methodology for a rapid and high-throughput comparison of molecular profiles and biological activity of phytoextracts
  27. Alternative Serum Biomarkers of Bacteraemia for Intensive Care Unit Patients
  28. Comparison of Analytical Methods Of Serum Untargeted Metabolomics
  29. The Impact of the Serum Extraction Protocol on Metabolomic Profiling Using UPLC-MS/MS and FTIR Spectroscopy
  30. Label-free discrimination of T and B lymphocyte activation based on vibrational spectroscopy – A machine learning approach
  31. Quality Monitoring of Biodiesel and Diesel/Biodiesel Blends: A Comparison between Benchtop FT-NIR versus a Portable Miniaturized NIR Spectroscopic Analysis
  32. Epigenetic and Drug Response Modulation of Epigalocaten-In-3-Gallate in Staphylococcus aureus with Divergent Resistance Phenotypes
  33. Plasma versus Serum Analysis by FTIR Spectroscopy to Capture the Human Physiological State
  34. Antimicrobial evaluation of the Cynara cardunculus extract in Helicobacter pylori cells using mid-infrared spectroscopy and chemometric methods
  35. Proteomics for Biomarker Discovery for Diagnosis and Prognosis of Kidney Transplantation Rejection
  36. Ovine Model as a Temporomandibular Disc Substitute: Characterisation and the Outcomes of Freezing Storage
  37. Antigenic and conserved peptides from diverse Helicobacter pylori antigens
  38. Infection Biomarkers Based on Metabolomics
  39. Development of a biocompatible hydrogel based on native temporomandibular joint extracellular matrix powder
  40. Fast identification of off‐target liabilities in early antibiotic discovery with Fourier‐transform infrared spectroscopy
  41. A new method to predict genotoxic effects based on serum molecular profile
  42. Technologies for High-Throughput Identification of Antibiotic Mechanism of Action
  43. VARIABILITY OF NEUTROPHIL-ACTIVATING PROTEIN AMONG HELICOBACTER PYLORI STRAINS
  44. Comparison of partial least squares‐discriminant analysis and soft independent modeling of class analogy methods for classification of Saccharomyces cerevisiae cells based on mid‐infrared spectroscopy
  45. Simultaneous elucidation of antibiotic mechanism of action and potency with high-throughput Fourier-transform infrared (FTIR) spectroscopy and machine learning
  46. Potential of FTIR-Spectroscopy for Drugs Screening against Helicobacter pylori
  47. Discriminating B and T-lymphocyte from its molecular profile acquired in a label-free and high-throughput method
  48. FTIR spectroscopy applications for biomedicine
  49. A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
  50. Metabolic Fingerprinting with Fourier-Transform Infrared (FTIR) Spectroscopy: Towards a High-Throughput Screening Assay for Antibiotic Discovery and Mechanism-of-Action Elucidation
  51. A phenotypic screening bioassay forEscherichia colistress and antibiotic responses based on Fourier‐transform infrared (FTIR) spectroscopy and multivariate analysis
  52. Antibiotic Discovery: Where Have We Come from, Where Do We Go?
  53. Characterization of gastric cells infection by diverse Helicobacter pylori strains through Fourier-transform infrared spectroscopy
  54. Assessing the molecular fingerprint of T lymphocyte activation
  55. Spectral Biomarkers of Genotoxicity from Methanol Extracts of Blood
  56. Impact of the solvent extraction method on the plasma metabolome profile
  57. Classification of recombinant Saccharomyces cerevisiae cells using PLS-DA modelling based on MIR spectroscopy
  58. Effect of culturing human embryos in group on the composition of spent culture media
  59. Towards an automated statistical workflow for biomarker screening in Fourier-transform infrared spectroscopy
  60. Impact of the human mesenchymal stem cells donor on conditional medium composition
  61. Effect of consumption of green tea extracts on the plasma molecular signature
  62. Helicobacter pylori Persistence Throughout the Host Life as a High Risk of Peptic Ulcers, Gastric Cancer and MALT Lymphoma
  63. Determination of Cell Abundances and Paralytic Shellfish Toxins in Cultures of the Dinoflagellate Gymnodinium catenatum by Fourier Transform Near Infrared Spectroscopy
  64. Assessing plasmid bioprocess reproducibility and C-source uptake stage through multivariate analysis of offline and online data
  65. Comparative analysis of different transformed Saccharomyces cerevisiae strains based on high-throughput Fourier transform infrared spectroscopy
  66. High-throughput FTIR-based bioprocess analysis of recombinant cyprosin production
  67. Optimization of a bioassay to evaluate Escherichia coli stress responses
  68. Biopharmaceuticals process monitoring based on infrared spectroscopy according to Quality by Design
  69. High-throughput bioassay for mechanism of action determination of antibacterial drugs
  70. Mid-infrared spectroscopy: A groundbreaking tool for monitoring mammalian cells processes
  71. Does Nonlinear Modeling Play a Role in Plasmid Bioprocess Monitoring Using Fourier Transform Infrared Spectra?
  72. Metabolic profiling of recombinantEscherichia colicultivations based on high-throughput FT-MIR spectroscopic analysis
  73. Monitoring theex-vivoexpansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy
  74. A comprehensive high-throughput FTIR spectroscopy-based method for evaluating the transfection event: estimating the transfection efficiency and extracting associated metabolic responses
  75. In Situ Near-Infrared (NIR) versus High-Throughput Mid-Infrared (MIR) Spectroscopy to Monitor Biopharmaceutical Production
  76. Molecular fingerprint of human gastric cell line infected by Helicobacter pylori
  77. Development of a high-throughput monitoring technique of bacteria photodynamic inactivation
  78. Process Analytical Technologies in Biopharmaceutical Process Development
  79. In situ near infrared spectroscopy monitoring of cyprosin production by recombinant Saccharomyces cerevisiae strains
  80. Kinetic modeling of plasmid bioproduction in Escherichia coli DH5α cultures over different carbon-source compositions
  81. In situNIR spectroscopy monitoring of plasmid production processes: effect of producing strain, medium composition and the cultivation strategy
  82. Real-time plasmid monitoring of batch and fed-batch Escherichia coli cultures by NIR spectroscopy
  83. High-throughput analysis of the plasmid bioproduction process in Escherichia coli by FTIR spectroscopy
  84. Development and characterization of a new plasmid delivery system based on chitosan–sodium deoxycholate nanoparticles
  85. The importance of Helicobacter pylori's genetic variability for the construction of an efficient vaccine
  86. Modelling, monitoring and control of plasmid bioproduction in Escherichia coli cultures
  87. Protein and DNA nanoparticulate multiantigenic vaccines against H. pylori: In vivo evaluation
  88. A Nonionic Porphyrin as a Noninterfering DNA Antibacterial Agent
  89. Use of chemometrics in the selection of a Saccharomyces cerevisiae expression system for recombinant cyprosin B production
  90. Antigenic Diversity Among Portuguese Clinical Isolates of Helicobacter pylori
  91. Biodegradable nanoparticles of alginate and chitosan as non-viral DNA oral delivery system
  92. Monitoring bacterial processes by Fourier transform infrared spectroscopy: Helicobacter pylori drug inactivation and plasmid bioproduction in recombinant Escherichia coli cultures
  93. Optimization of the culture medium composition using response surface methodology for new recombinant cyprosin B production in bioreactor for cheese production
  94. A novel multifunctional DNA vaccine expresses conserved and immunogenic fragments of six Helicobacter pylori proteins
  95. The carbon-source on the efficiency of plasmid production in high density cultures of Escherichia coli
  96. Influence of tryptophan tags on the purification of cutinase, secreted by a recombinant Saccharomyces cerevisiae, using cationic expanded bed adsorption and hydrophobic interaction chromatography
  97. Prediction of retention time of cutinases tagged with hydrophobic peptides in hydrophobic interaction chromatography
  98. A flow injection analysis system for on‐line monitoring of cutinase activity at outlet of an expanded bed adsorption column almost in real time
  99. Micro-analytical GO/HRP bioreactor for glucose determination and bioprocess monitoring
  100. Integration of the production and the purification processes of cutinase secreted by a recombinant Saccharomyces cerevisiae SU50 strain
  101. Recombinant Saccharomyces cerevisiae strain triggers acetate production to fuel biosynthetic pathways
  102. Pressure-tuning FTIR Spectroscopy: Applications to Biomedical Research and Diagnosis
  103. Towards a cost effective strategy for cutinase production by a recombinant Saccharomyces cerevisiae: strain physiological aspects
  104. Integration of production and aqueous two-phase systems extraction of extracellular cutinase fusion proteins
  105. Development of a Fed-Batch Cultivation Strategy for the Enhanced production and Secretion of Cutinase by a Recombinant Saccharomyces cerevisiae SU50 Strain
  106. Development of a Fed-Batch Cultivation Strategy for the Enhanced Production and Secretion of Cutinase by a Recombinant Saccharomyces cerevisiae SU50 Strain
  107. Effect of Saccharomyces cerevisiae fermentation conditions on expanded bed adsorption of heterologous cutinase
  108. Optimisation of culture conditions and characterisation of cutinase produced by recombinant Saccharomyces cerevisiae
  109. Production of wild-type and peptide fusion cutinases by recombinantSaccharomyces cerevisiae MM01 strains
  110. Effect of pre-fermentation on the production of cutinase by a recombinant Saccharomyces cerevisiae